One strong reason for the increased SHIP1 expression detected in some malignant B-ALL cells could be that the cells had a survival advantage in clonal B-cell selection due to the functional implication of SHIP1 to downregulate overactivated BCR signaling events [9]. This evidence concerns the gene BCR and acute lymphoblastic leukemia.